Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
ERES IV acquires a majority stake in Oncodesign Services

ERES IV acquires a majority stake in Oncodesign Services

Multiomics analysis of kidney metabolism reveals a gatekeeper for viral infections

Multiomics analysis of kidney metabolism reveals a gatekeeper for viral infections

Updated EULAR recommendations on the use of DMARDs for people with RA

Updated EULAR recommendations on the use of DMARDs for people with RA

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

Fruquintinib provides survival benefits for patients with refractory metastatic colorectal cancer

Fruquintinib provides survival benefits for patients with refractory metastatic colorectal cancer

Triplet therapy slows progression of advanced kidney cancer

Triplet therapy slows progression of advanced kidney cancer

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

New anti-cancer drug candidate is absorbed through the lymphatic system rather than blood vessels

Pigment epithelium-derived factor ablations may lead to eye aging

Pigment epithelium-derived factor ablations may lead to eye aging

Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

MD Anderson announces collaborative alliance with Turning Point Therapeutics to advance new treatment options for cancer patients

MD Anderson announces collaborative alliance with Turning Point Therapeutics to advance new treatment options for cancer patients

New combination of drugs effective against T-cell acute lymphoblastic leukemia

New combination of drugs effective against T-cell acute lymphoblastic leukemia

Moffitt researchers reveal a mechanism leading to drug resistance in prostate cancer

Moffitt researchers reveal a mechanism leading to drug resistance in prostate cancer

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

Scientists identify a way to reverse drug resistance by rewiring the inner workings of leukemia cells

Scientists identify a way to reverse drug resistance by rewiring the inner workings of leukemia cells

New tactic to disrupt cancer repair mechanism could lead to a potential treatment strategy

New tactic to disrupt cancer repair mechanism could lead to a potential treatment strategy